Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
07/2003
07/15/2003US6593137 Antibodies specific for fullerenes
07/15/2003US6593136 Culturing cells in a chamber in a stack of chambers
07/15/2003US6593135 Quantitative analysis
07/15/2003US6593134 Propagation of chicken infectious anemia virus; prepare nutrient broth, inoculate with cells infected with marek's disease, propagate, recover infected cells
07/15/2003US6593133 Neurotrophic factors
07/15/2003US6593129 Apparatus for use in the injection of material into amphibian oocytes
07/15/2003US6593124 Hybrid genes for expression of stimulatory factors in activated T cells
07/15/2003US6593122 Nucleotide sequences coding enzymatic polypeptide for use as tools in genetic engineering
07/15/2003US6593121 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of nervous system disorders
07/15/2003US6593119 Core 2 β-1,6-N-acetylglycosaminyltransferase gene
07/15/2003US6593111 Generating genetically engineered viral genome; obtain clones, incubate with restriction enzymes, recover nucleotide sequence, ligate and generate viral genome
07/15/2003US6593109 Culturing cells containing DNA sequences under the control of a regulatory sequence capable of directing expression; useful in treating bone defects, healing bone injury and wounds
07/15/2003US6593108 Nucleic acid molecule encoding a melanin-concentrating hormone receptor 2 polypeptide
07/15/2003US6593105 Vector comprising a nucleic acid insert; alteration of amino acids within the helix-1 region; inability to convert to a disease-associated form; use in prophylaxis/gene therapy for neurodegenerative diseases
07/15/2003US6593103 HIV capsid assembly-associated compositions and method
07/15/2003US6592886 Producing stable cross-linked alginate gel by binding surplus cations with anions
07/15/2003US6592874 Togavirus capsid particle that does not contain genomic or RNA vector replicon nucleic acids
07/15/2003US6592868 Produced by hybridoma having ATCC Accession Number HB 10916
07/15/2003US6592864 Treating pulmonary hypertension; administering transfected cells containing an expressible transgene directly into pulmonary system
07/15/2003US6592618 In vitro modification of cardiac valvular xenografts
07/15/2003CA2139864C Use of a calcium carbonate based porous material as support for a growth factor in the preparation of a bioabsorbable implant
07/10/2003WO2003056022A2 Method for producing a transgenic organism using a lentiviral expression vector such as eiav
07/10/2003WO2003056020A2 Expression vectors and promoters for heterologous gene expression
07/10/2003WO2003056019A1 Method of transducing es cells
07/10/2003WO2003056017A2 Alkaline protease from bacillus sp. (dsm 14390) and washing and cleaning products comprising said alkaline protease
07/10/2003WO2003056013A1 TGF-β-SPECIFIC COVALENTLY CLOSED ANTISENSE MOLECULE
07/10/2003WO2003056012A1 A system for stable expression of sirnas in mammalian cells
07/10/2003WO2003055994A1 Hxhv virus, nucleic material, peptide material and uses
07/10/2003WO2003055992A2 A method for the establishment of a pluripotent human blastocyst-derived stem cell line
07/10/2003WO2003055991A1 Igamete recruitment and developmental competence in mammals by inhibiting the de novo sterol biosynthesis and/or promoting sterol efflux
07/10/2003WO2003055990A2 Method for culturing and expansion of mammalian undifferentiated epidermal keratinocytes exhibiting stem cell characteristics
07/10/2003WO2003055989A2 Cellular compositions and methods of making and using them
07/10/2003WO2003055988A1 An avian embryo particulate biomass for the production of virus antigens
07/10/2003WO2003055983A2 Targeted retrograde gene delivery to motor neurons
07/10/2003WO2003055980A2 Il-17 like molecules and uses thereof
07/10/2003WO2003055974A2 Novel alkaline protease from bacillus sp. (dsm 14392) and washing and cleaning products comprising said novel alkaline protease
07/10/2003WO2003055916A2 Adiponectin fragments and conjugates
07/10/2003WO2003055915A2 Human netrin receptor and uses thereof
07/10/2003WO2003055913A2 Secreted protein
07/10/2003WO2003055912A2 Secreted proteins
07/10/2003WO2003055911A2 Cystine-knot fold protein
07/10/2003WO2003055910A1 Beta-amyloid binding factors and inhibitors thereof
07/10/2003WO2003055906A1 Modified bacterial surface layer proteins
07/10/2003WO2003055440A2 Compositions and methods for the treatement of immune related diseases
07/10/2003WO2003055302A1 Knockout swine and methods for making the same
07/10/2003WO2003033677A3 Dimerized growth factor and materials and methods for producing it
07/10/2003WO2003027245A3 CONVERSION OF RED BLOOD CELLS A, B, AND AB USING a-N-ACETYLGALACTOSAMINIDASES AND a-GALACTOSIDASE
07/10/2003WO2003024992A3 HUMAN AND MOUSE β-DEFENSINS, ANTIMICROBIAL PEPTIDES
07/10/2003WO2003020871A3 Method and device for the in vitro cultivation of cells
07/10/2003WO2003008452A3 Bispecific monoclonal antibodies to il-12 and il-18 receptors
07/10/2003WO2003007880A3 Inhibition of behab cleavage and primary central nervous system (cns) tumors
07/10/2003WO2003002749A3 Methods for the simultaneous detection of hcv antigens and hcv antibodies
07/10/2003WO2002092625A3 Moraxella(branhamella) catarrhalis antigens
07/10/2003WO2002090520A3 Toll/interleukin-1 receptor adaptor protein (tirap)
07/10/2003WO2002074956A3 Dopaminergic neuronal survival-promoting factors and uses thereof
07/10/2003WO2002072788A3 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses
07/10/2003WO2002063008A3 Intracellular signaling molecules
07/10/2003WO2002059326A3 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
07/10/2003WO2002059278A3 Differentiation of stem cells to pancreatic endocrine cells
07/10/2003WO2002059267A3 Constitutively desensitized g protein-coupled receptors
07/10/2003WO2002046409A3 Proteins and nucleic acids encoding same
07/10/2003WO2002040541A3 Transporters and ion channels
07/10/2003WO2002018581A3 G-protein coupled receptors
07/10/2003WO2002012281A3 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
07/10/2003WO2002010768A9 Model for alzheimer's disease and other neurodegenerative diseases
07/10/2003WO2002000730A9 Pd-l2 molecules: novel pd-1 ligands and uses therefor
07/10/2003WO2001096523A3 Polynucleotides related to colon cancer
07/10/2003WO2001089364A9 Hcv variants
07/10/2003WO2001082784A3 Enhanced biologically based chronotropic biosensing
07/10/2003US20030131384 Generating transgenic plants; controlling tumor protein
07/10/2003US20030131383 Peptides with enhanced stability to protease degradation
07/10/2003US20030131381 Novel ecdysone receptors and methods for their use
07/10/2003US20030131380 Coffee mannanase
07/10/2003US20030131374 Pepper gene promoters; drives gene expression in transgenic plants
07/10/2003US20030131370 Disruption of the glutathione S-transferase-Omega-1 gene
07/10/2003US20030131368 KV1.7 potassium channel disruptions, compositions and methods relating thereto
07/10/2003US20030131367 Kv3.3b potassium channel disruptions, compositions and methods related thereto
07/10/2003US20030130747 Bioengineered flat sheet graft prostheses
07/10/2003US20030130494 Mammalian chemokine reagents
07/10/2003US20030130492 A purified polynucleotide encoding polypeptides for detecting, diagnosing, monitoring, preventing or treating breast cancer; genetic engineering
07/10/2003US20030130491 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030130490 Genetic engineered protein drugs, such as thrombolytic agents, interferons, interleukins, erythropoietins; extracellular
07/10/2003US20030130489 Genetic engineered protein drugs, such as thrombolytic agents, interferons, interleukins, erythropoietins
07/10/2003US20030130483 Amino acid sequences free of signal peptide, encoded by cDNA; fusion proteins
07/10/2003US20030130222 Apoptosis; modulate gene expression; central nervous system disorders; anticancer agents; Aids therapy
07/10/2003US20030130218 Methods of stimulating phagocytosis
07/10/2003US20030130217 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
07/10/2003US20030130196 Administering angiotensin; antitumor agents; side effect reduction
07/10/2003US20030130187 Porcine adenovirus type 3 genome
07/10/2003US20030130182 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030130181 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030129752 MEKK/JNKK-contingent (mitogen extracellular signal regulated kinases (MEKK), Jun N-terminal kinase) signal transduction pathway; tumor necrosis factor; interleukins
07/10/2003US20030129751 Loading into biocompatible polylactide scaffold and implanting
07/10/2003US20030129750 Inducing vascular growth in tissue via administration of cytokine, chemokine, or chemoattractant; for treatment of cardiac ischemia; tissue engineering
07/10/2003US20030129749 Comprises isogeneic antigen presenting cells
07/10/2003US20030129748 Enginerred bone marrow
07/10/2003US20030129747 Screening for fibronectins in post-natal mammals
07/10/2003US20030129746 Monoclonal antibodies for Hepatitis C virus (HCV) infection
07/10/2003US20030129745 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
07/10/2003US20030129744 Bvdv virus-like particles
1 ... 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 ... 1827